Dataset ID: 15

Back to List

Dataset Details

Study Design
Study Design Background
Development of metrics for improving tumor pH quantification in presence of fat
Study Description
CEST tumor pH fat correction
Study Type
Preclinical
Study Subtype
In vitro in vivo
Publication
Paper Linked
Yes
Paper Title
Development and Validation of Four Different Methods to Improve MRI-CEST Tumor pH Mapping in Presence of Fat
Paper Authors
Gammaraccio F, Villano D, Irrera P, Anemone AA, Carella A, Corrado A, Longo DL
Affiliation
Institute of Biostructures and Bioimaging (IBB), Italian National Research Council (CNR), Torino, Italy; Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy;
Paper Journal
Journal of Imaging
Paper Year
2024
Paper DOI
Open Access
Yes
Study Component
Multi Modality Images
No
Imaging Modality
Imaging Sub Modality
Radiation
No
Imaging Coverage
Abdomen
Imaging Target
Tumor
Dataset Information
Institution
CNR-IBB
PI
Dario Longo
Country Of Institution
Italy
Imaging Facility
CNR-IBB Torino
Euro Bio Imaging Node
MMMI
Country Of Imaging Facility
Italy
Link To Dataset
Funding
Yes
Funding Agency
Associazione Italiana Ricerca sul Cancer (AIRC)
Grant Number
MFAG 2017 #20153
Dataset Access
Public
License
DUO Data Use Permission
DUO-0000042
DUO Data Use Modifier
DUO-0000019, DUO-0000046
DUO Investigation
DUO-0000037, DUO-0000040, DUO-0000031
Contact Person
In Vivo Experimental Parameters
Number Of Groups
2
Types Of Groups
Low fat, high fat
Overall Sample Size
2
Disease Model
Organ Or Tissue
Mammary gland
Sample Size For Each Group
1.1
Randomization
No
Procedures To Keep Treatments Blind
No
Outcome Measures
CEST contrast, tumor pH
Species
Strain
Balb C, MMTV-PyMT
Immune Status
Immunecompetent
Sex
Female, female
Age
7 weeks, 8 weeks
Weight
25 grams
Genotype
Heterozygous
Genetic Manipulation
Transgenic
Source Of Animals
Charles River Laboratories Italia srl, Calco Italy; The Jackson Laboratory, Bar Harbor, ME, USA
Experimental Procedures
Pharmacological Procedures Intervention And Control
No
Blood Sampling
No
Surgical Procedures Including Sham Surgery
No
Pathogen Infection Intervention And Control
No
Analgesic Plan To Relieve Pain Suffering And Distress
No
Anesthesia Type
Intramuscular
Duration
40
Anesthesia Drugs
Xylazine (Rompun, Bayer, Italy), tiletamine zolazepam (Zoletil 100, Virbac, Italy)
Anesthesia Dose
5 mg kg, 20 mg kg
Euthanasia
Yes
Method
Cervical dislocation
Histology
No
Frequency Of Imaging
Single scan
Overall Scan Length
40 minutes
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule
Yes
Contrast Agent Commercial Drug
Isovue
Contrast Agent Chemical Drug
Iopamidol
Contrast Agent Dose
4 g kg
Injection Volume
0.25
Route Of Administration
Intravenous
Cell Line
Provenance
Molecular Biotechnology Center Cell Factory
Modified Cell Line
No
Cell Injection Route
Subcutaneous
Number Of Cells
1000000
Housing Room
Not SPF
Dietary Intervention
No
Respiration Rate
No
Body Tempurature Etc
No
Food Intake Measured
No
Image Acquisition
Instrument Vendor
Bruker
Instrument Type
Microimaging
Instrument Specifics
7T
Raw Data
Yes
QA/QC
No
Image Data
Image Type
Primary image processed image
Image Scale
Signal intensity
Format Compression
DICOM
Dimensions
4D (3D + frequencies)
Overall Number Of Images
16
Field Of View
30x30x1.5 mm
Dimension Extents
128x128x8
Size Description
30x30x12 mm
PI xel Voxel Size Description
0,234x0,234x1,5 mm
Image Processing Methods
Default reconstruction
Quality Control
No
Image Registration Algorithm
No
Ai Enhanced Algorithm
Yes
QC Info
R2 calculation on raw CEST data
Analyzed Data
Analysis Result Type
Numerical analysis
Data Used For Analysis
PH maps
Analysis Method And Details
Manual delineation of tumor regions (ROI), MATLAB
File Format Of Result File Csv Json Txt Xlsx
Jpg, txt, mat
Status
Complete
Updated Year
2024